Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The clinical trial is designed to evaluate the safety of inhaled Technosphere/Insulin
compared with non-inhaled anti-diabetic therapies in subjects with type 1 or type 2 diabetes
mellitus and concurrent asthma.